Concepedia
Statistics
Publications
20
Citations
1.2K
H-Index
16
Active since
1992
Affiliations
Abbott Fund(Current)
Lund University
Abbott (United States)
Forma Therapeutics (United States)
Centro Nacional de Biotecnología
Anna Ericsson is an author at Abbott Fund specializing in medicinal chemistry, pharmacology, and pharmacy.
Publications per year
1992–2020
CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa
Marcus Svensson, Jan Marsal, Anna Ericsson et al. · Journal of Clinical Investigation · 2002 · 309 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Gut-associated lymphoid tissue–primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine
Hanna Stenstad, Anna Ericsson, Bengt Johansson‐Lindbom et al. · Blood · 2006 · 174 citations
Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor
Justin A. Caravella, Jian Lin, R. Bruce Diebold et al. · Journal of Medicinal Chemistry · 2020 · 144 citations · Full text
Pharmacy, Oncology, Pharmacology +15
Palladium-Catalyzed Regioselective Addition of Thiophenol to Conjugated Enynes. Efficient Syntheses of 2-(Phenylsulfinyl) and 2-(Phenylsulfonyl) 1,3-Dienes
Jan‐E. Baeckvall, Anna Ericsson · The Journal of Organic Chemistry · 1994 · 109 citations
Natural Sciences, Chemistry, Catalysis +8
CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes
Anna Ericsson, Marcus Svensson, Anu Arya et al. · European Journal of Immunology · 2004 · 103 citations · Full text
1–5 of 20